Sean Brynjelsen

Chief Executive Officer bij ETON PHARMACEUTICALS, INC.

Vermogen: 4 M $ op 31-03-2024

52 jaar

Health Technology

Consumer Services

Actieve functies van Sean Brynjelsen

Bedrijven	Functie	Begin	Einde
ETON PHARMACEUTICALS, INC.	Director/Board Member	01-06-2017	-
	Chief Executive Officer	01-06-2017	-
	President	01-06-2017	-

Bedrijven	Functie	Begin	Einde
SAGENT PHARMACEUTICALS INC	Corporate Officer/Principal	23-03-2016	01-06-2017
AKORN, INC.	Chief Tech/Sci/R&D Officer	18-06-2010	07-02-2014
AKORN, INC.	Corporate Officer/Principal	07-02-2014	01-03-2016

University of Notre Dame	Masters Business Admin
University of Illinois	Graduate Degree

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Masters Business Admin	1

Sectoraal

Health Technology	4
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
ETON PHARMACEUTICALS, INC.	Health Technology

Bedrijven in privébezit	2
Akorn, Inc. Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.	Health Technology
Sagent Pharmaceuticals, Inc. Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.	Health Technology

Bedrijven in privébezit

Health Technology